VR Serum Ingredients: Deionized Water, Hyaluronic Acid, Water (and) Pentylene Glycol (and) 1, 2, Hexanediol (and) Sodium Phosphate (and) Lecithin (and) sh-Polypeptide-10, sh-Polypeptide-9, sh-Polypeptide-3, sh-Polypeptide-22, Acetyl Octapeptide-17 Amide, Sodium Benzoate, Chorphenesin, Potassium Sorbate
Active Ingredients:
Keratinocyte Growth Factor (KGF) sh-Polypeptide-3: :Stimulates the proliferation of the vaginal mucosa
Vascular Endothelial Growth Factor (VEGF) sh-Polypeptide-9: Stimulates the proliferation of the vaginal mucosa and natural lubrication
Keratinocyte Growth Factor-2 (KGF 2) sh-Polypeptide-10: Increases the thickness and strengthens the vaginal tissue’s protective cells
Epidermal Growth Factor (EGF) Acetyl Octapeptide-17 Amide: Effective in the treatment of epidermal atrophy
Transforming Growth Factor Beta 1 (TGFB 1) sh-Polypeptide 22: Transforming Growth Factor Beta 1 is involved in the healing process and helps modulate fibroblast growth and normalize the vaginal mucosa
Hyaluronic Acid: Used for Hydration: Hyaluronic acid is a natural moisturizer that binds to water and draws it into the skin, helping to maintain a healthy balance of moisture
Inactive Ingredients:
Water (and) Pentylene Glycol (and) 1, 2, Hexanediol (and) Sodium Phosphate (and) Lecithin (preservatives for the growth factors listed above)
Sodium Benzoate prevents the growth of bacteria, fungi, and yeast, which helps extend the shelf life of cosmetic products
Chorphenesin preservative
Potassium Sorbate preservative
SKINGENUITY® VR – Vaginal Reguvenation Gel (SKINGENUITY® VR) aims to be the first line treatment for Vaginal Rejuvenation using our patent pending technology.
SKINGENUITY® VR Gel can be used to help with the symptoms of Vaginal Laxity, Genitourinary Symptoms of Menopause (GSM) as well as being used in combination with Laser Vaginal Rejuvenation.
SKINGENUITY® VR Gel has been clinically tested and was found to have a significant improvement in the main measures of vaginal health as defined in the Vaginal Health Index1.
The aim of any Vaginal Rejuvenation treatment is to help improve the vaginal lining, which has been thinned mainly due to a change in estrogen levels post menopause.
The term Vaginal Rejuvenation has been used extensively in the media and generally to describe any aesthetic treatment related to the Vagina. The treatments that are on offer are used to treat Genitourinary Syndrome of Menopause (GSM). GSM is a new term that describes various menopausal symptoms and signs including not only genital symptoms (dryness, burning, and irritation), and sexual symptoms (lack of lubrication, discomfort or pain, and impaired function, but also urinary symptoms (urgency, dysuria, and recurrent urinary tract infections) which are a consequence of aging, particularly after menopause. GSM can significantly affect a patient’s quality of life and is common
among women who have been through the menopause with report of up to 45% of post-menopausal women whose quality of life has been negatively impacted.
SKINGENUITY® VR Gel improves the symptoms of GSM?
SKINGENUITY® VR Gel has been clinically tested and was found to have a significant improvement in the main measures of vaginal health as defined in the Vaginal Health Index2. The Vaginal Health Index (VHI) is a system used to evaluate vaginal elasticity, fluid volume, pH, epithelial integrity, and moisture on a scale of 1 to 5.
How does SKINGENUITY® VR Gel work?
SKINGENUITY® VR Gel can be used to help with the symptoms of Vaginal Laxity, Genitourinary Symptoms of Menopause (GSM) as well as being used in combination with Laser Vaginal Rejuvenation.
SKINGENUITY® VR Gel contains focussed and targeted Growth Factors that are nano-encapsulated to ensure penetration into the vaginal mucosal lining.
SKINGENUITY® VR Gel has been proven quantitatively in Clinical Trials to significantly improve the main symptoms of GSM.
The Growth Factors have all been proven to help improve the atrophy of the vaginal lining.
Reviews
There are no reviews yet.